Some directors and senior management of Hisense Pharmaceutical (001367.SZ) plan to reduce their holdings by no more than 124,300 shares in total

Zhitongcaijing · 1d ago

According to Zhitong Finance App, Hysen Pharmaceutical (001367.SZ) issued an announcement. Some directors and senior management of the company plan to reduce their holdings of the company's shares by a total of 124,300 shares (0.0816% of the company's total share capital) through centralized bidding transactions within 3 months after 15 trading days from the date of disclosure of this announcement (that is, December 26, 2025 to March 25, 2026).